Lobbying registration dated 2026-04-01
Registrant: Amanda McLaren
Client: Vimy Pharmaceuticals Inc.
Targeted institutions:
Privy Council Office (PCO)
Federal Economic Development Agency for Southern Ontario (FedDev)
House of Commons
Prime Minister's Office (PMO)
Veterans Affairs Canada (VAC)
Health Canada (HC)
Indigenous Services Canada (ISC)
Prairies Economic Development Canada (PrairiesCan)
Finance Canada (FIN)
Innovation, Science and Economic Development Canada (ISED)
Government funding received:
Lobbying activity details:
Communicating with government officials regarding regulatory requirements for the domestic manufacturing and market entry of generic semaglutide in Canada.